Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on engineering antibodies into impactful medicines to treat infectious diseases and cancer. Since 2025, Humabs BioMed AG (acquired by Vir Biotechnology in 2017) operates with a unified brand with Vir Biotechnology.
- http://www.vir.bio
- +41 91 825 63 80
- Send an email
- Filippo Riva